Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study (Q38758330)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 May 2017

Language	Label	Description	Also known as
English	Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study	scientific article published on 26 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

Donna MacKinnon-Cameron

4

object named as

Donna MacKinnon-Cameron

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

21

object named as

Grant Stiver

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

20

object named as

Makeda Semret

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sylvie Trottier

22

object named as

Sylvie Trottier

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Louis Valiquette

23

object named as

Louis Valiquette

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

18

object named as

Allison McGeer

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

6

object named as

Ardith Ambrose

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jennie Johnstone

15

object named as

Jennie Johnstone

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5

object named as

Li Li

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

12

object named as

Guy Boivin

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Shelly A McNeil

25

object named as

Shelly A McNeil

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Melissa K Andrew

11

object named as

Melissa K Andrew

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Rachel Karen Green

14

object named as

Karen Green

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

7

object named as

Todd F Hatchette

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

16

object named as

Mark Loeb

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

24

object named as

Duncan Webster

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

2

object named as

May ElSherif

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jason J LeBlanc

1

object named as

Jason J LeBlanc

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)

26

object named as

Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Hayley D Gillis

9

object named as

Hayley Gillis

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Lingyun Ye

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Amanda L Lang

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Irene Martin

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

William Bowie

13

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Anne McCarthy

17

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sanela Moraca

19

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

0 references

publication date

26 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

3647-3654

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Pneumococcal infection in adults: burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

A standard procedure for creating a frailty index.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Detection and prediction of Streptococcus pneumoniae serotypes directly from nasopharyngeal swabs using PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Diagnostic tests for agents of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Influence of Childhood Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Adults With Underlying Comorbidities in Calgary, Alberta (2000-2013).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.049

7 January 2021

Identifiers

10.1016/J.VACCINE.2017.05.049

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38758330&oldid=2158211262"